ProPhase Labs Stock: A Growth Stock At An Attractive Valuation (NASDAQ:PRPH)
ProPhase Labs has expanded its in-house testing capabilities for the diagnostics of the new clinical chemistry, immunoassay, hematology, hemostasis, and urinalysis analyzers.
ProPhase Labs Stock: A Growth Stock At An Attractive Valuation (NASDAQ:PRPH)
ProPhase Labs has expanded its in-house testing capabilities for the diagnostics of the new clinical chemistry, immunoassay, hematology, hemostasis, and urinalysis analyzers.